References
- Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337:1733–45.
- McMahon BJ. Hepatocellular carcinoma and viral hepatitis. Wilson RA. Viral hepatitis. New York, NY: Marcel Dekker; 1997. 315–30.
- Fattovich G, Brollo L, Giustina G, Noventa F, Pontisso P, Alberti A, . Natural history and prognostic factors for chronic hepatitis type B. Gut 1991;32:294–8.
- Yu MW, Hsu FC, Sheen IS, Chu CM, Lin DY, Chen CJ, . Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 1997;145:1039–47.
- Shah U, Kelly D, Chang MH, Fujisawa T, Heller S, Gonzalez-Peralta RP, . Management of chronic hepatitis B in children. J Pediatr Gastroenterol Nutr 2009;48: 399–404.
- Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2001;34:1225–41.
- Dienstag J. The role of liver biopsy in chronic hepatitis C. Hepatology 2002;36:152–60.
- Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495–500.
- Poynard T, Ratziu V, Bedossa P. Appropriateness of liver biopsy. Can J Gastroenterol 2000;14:543–8.
- Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, . Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97:2614–8.
- Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003;39:239–44.
- Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289–93.
- Poynard T, Imbert-Bismut F, Munteanu M, Messous D, Myers RP, Thabut D, . Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 2004;3:8–19.
- Poynard T, Morra R, Ingiliz P, Imbert-Bismut F, Thabut D, Messous D, . Biomarkers of liver fibrosis. Adv Clin Chem 2008;46:131–60.
- Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, Imbert-Bismut F, . Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol 2003;39:222–30.
- Halfon P, Munteanu M, Poynard T. Fibrotest–Actitest as a non-invasive marker of liver fibrosis. Gastroenterol Clin Biol 2008;32:22–39.
- Rossi E, Adams L, Prins A, Bulsara M, de Boer B, Garas G, . Validation of Fibro Test biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem 2003;49:450–4.
- Hermeziu B, Messous D, Fabre M, Munteanu M, Baussan C, Bernard O, . Evaluation of FibroTest–ActiTest in children with chronic hepatitis C virus infection. Gastroenterol Clin Biol 2010;34:16–22.
- Breton E, Bridoux-Henno L, Guyader D, Danielou H, Jouan H, Beuchee A, . Value of transient elastography in noninvasive assessment in children's hepatic fibrosis. Arch Pediatr 2009;16:1005–10.
- Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, . Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696–9.
- McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990;99:1396–400.
- Blanc JF, Bioulac-Sage P, Balabaud C, Desmouliere A. Investigation of liver fibrosis in clinical practice. Hepatol Res 2005; 32:1–8.
- Sebastiani G, Vario A, Guido M, Alberti A. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2007;13:525–31.
- Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, . Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431–5.
- Sebastiani G, Vario A, Guido M, Noventa F, Plebani M, Pistis R, . Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 2006;44:686–93.